MAP Pharmaceuticals

Biotechnology, Health Care, Medical, Pharmaceutical
Founded in 2003-01-01
Mountain View, California, United States
http://www.mappharma.com
For Profit

About MAP Pharmaceuticals

MAP Pharmaceuticals, Inc., a development stage company, focuses on developing novel inhalation therapies for respiratory and systemic diseases. It has various proprietary product candidates in clinical development, including Unit Dose Budesonide for pediatric asthma in children from six months to eight years of age and MAP0004 for migraine. The company's product portfolio also includes MAP0005 for the treatment of adolescent and adult asthma, and chronic obstructive pulmonary disease; and MAP0001 for the treatment of Type 1 and Type 2 diabetes via pulmonary delivery using its Tempo inhaler. MAP Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Mountain View, California.

Company Metrics

  • Employees: 51-100
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 105249000 USD
  • Last Funding: 50000000 USD (Series D)
  • Funding Status: M&A

Technology Stack

MAP Pharmaceuticals actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Medical, Pharmaceutical

Headquarters: Mountain View, California, United States